|
Infectious diseases
Citations 2021-2030 of 62552 total displayed.
|
Past content
(since Oct 1840):
|
-
- Endgames
- A man with a mass in the thigh
- Richard Bodington and Paul R W Stanley
-
BMJ 2014;348:g2483, doi: 10.1136/bmj.g2483,
-
[Extract]
[Full text]
[PDF]
-
- Editor's choice
- The missing data that cost $20bn
- Kamran Abbasi
-
BMJ 2014;348:g2695, doi: 10.1136/bmj.g2695,
-
[Extract]
[Full text]
[PDF]
-
- News
- Cochrane review questions effectiveness of neuraminidase inhibitors
- Ingrid Torjesen
-
BMJ 2014;348:g2675, doi: 10.1136/bmj.g2675,
-
[Extract]
[Full text]
[PDF]
-
- Analysis
- Oseltamivir: the real world data
- Nick Freemantle, L J Shallcross, D Kyte, T Rader, and M J Calvert
-
BMJ 2014;348:g2371, doi: 10.1136/bmj.g2371,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- Tamiflu: "a nice little earner"
- Andrew Jack
-
BMJ 2014;348:g2524, doi: 10.1136/bmj.g2524,
-
[Extract]
[Full text]
[PDF]
-
- Research
- Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
- Tom Jefferson, Mark Jones, Peter Doshi, Elizabeth A Spencer, Igho Onakpoya, and Carl J Heneghan
-
BMJ 2014;348:g2545, doi: 10.1136/bmj.g2545,
- [Abstract]
[Full text]
[PDF]
-
- Research
- Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
- Carl J Heneghan, Igho Onakpoya, Matthew Thompson, Elizabeth A Spencer, Mark Jones, and Tom Jefferson
-
BMJ 2014;348:g2547, doi: 10.1136/bmj.g2547,
- [Abstract]
[Full text]
[PDF]
-
- Editorials
- Neuraminidase inhibitors for influenza
- Harlan M Krumholz
-
BMJ 2014;348:g2548, doi: 10.1136/bmj.g2548,
-
[Extract]
[Full text]
[PDF]
-
- Editorials
- The Tamiflu trials
- Elizabeth Loder, David Tovey, and Fiona Godlee
-
BMJ 2014;348:g2630, doi: 10.1136/bmj.g2630,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- Tug of war for antiviral drugs data
- Julia Belluz
-
BMJ 2014;348:g2227, doi: 10.1136/bmj.g2227,
-
[Extract]
[Full text]
[PDF]
|